---
layout: post
title: "Revocation of Authorization of Emergency Use of an In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability"
date: 2026-02-05 18:58:31 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-05892
original_published: 2022-03-21 00:00:00 +0000
significance: 8.00
---

# Revocation of Authorization of Emergency Use of an In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 21, 2022 00:00 UTC
**Document Number:** 2022-05892

## Summary

The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorization (EUA) (the Authorization) issued to Abbott Diagnostics Scarborough, Inc. (Abbott) for the BinaxNOW COVID-19 Ag Card 2 Home Test. FDA revoked this Authorization under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The revocation, which includes an explanation of the reasons for revocation, is reprinted in this document.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/21/2022-05892/revocation-of-authorization-of-emergency-use-of-an-in-vitro-diagnostic-device-for-detection-andor)
- API: https://www.federalregister.gov/api/v1/documents/2022-05892

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
